{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Anti-platelet+therapy&page=3", "query": { "intervention": "Anti-platelet therapy", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 81, "total_pages": 9, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Anti-platelet+therapy&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Anti-platelet+therapy&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-05T05:53:35.685Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT05415150", "title": "Platelet Function in Patients With Ischemic Stroke Treated With Anti-thrombotic or Thrombolytic", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Acute Ischemic Stroke" ], "interventions": [ { "name": "Thrombolytic Agent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2022-02-18", "completion_date": "2024-05-31", "has_results": false, "last_update_posted_date": "2022-06-10", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05415150" }, { "nct_id": "NCT03939637", "title": "Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Immune Thrombocytopenia" ], "interventions": [ { "name": "Eltrombopag", "type": "DRUG" }, { "name": "Steroids", "type": "DRUG" }, { "name": "IVIG", "type": "DRUG" }, { "name": "Rho(D) Immune Globulin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "18 Years", "sex": "ALL", "summary": "1 Year to 18 Years" }, "enrollment_count": 122, "start_date": "2019-05-02", "completion_date": "2025-02-26", "has_results": true, "last_update_posted_date": "2025-07-29", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 22 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03939637" }, { "nct_id": "NCT01651208", "title": "Improving Adherence to Post PCI Antiplatelet Therapy in Minority Populations", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "Motivational Interviewing (MINT)", "type": "BEHAVIORAL" }, { "name": "Mailed DVD", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 452, "start_date": "2010-01", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2024-01-23", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01651208" }, { "nct_id": "NCT00323258", "title": "Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cardiovascular Disease" ], "interventions": [ { "name": "oral education & written tips for remembering medications", "type": "BEHAVIORAL" }, { "name": "pill box", "type": "DEVICE" }, { "name": "pocket medication card", "type": "DEVICE" }, { "name": "sharing information with community pharmacist", "type": "BEHAVIORAL" }, { "name": "Medication use evaluations by community pharmacist", "type": "BEHAVIORAL" }, { "name": "informing physician if patient has stopped a medication", "type": "BEHAVIORAL" }, { "name": "Routine discharge counseling", "type": "BEHAVIORAL" }, { "name": "Letter to physician/discharge summary", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "DEVICE", "OTHER" ], "sponsor": "Duke University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 143, "start_date": "2006-06", "completion_date": "2011-03", "has_results": true, "last_update_posted_date": "2013-01-18", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00323258" }, { "nct_id": "NCT01925794", "title": "COBRA PZF™ Coronary Stent for Early Healing, Thrombus Inhibition, Endothelialization and Avoiding Long-Term DAPT", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease" ], "interventions": [ { "name": "COBRA PzF", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "CeloNova BioSciences, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 296, "start_date": "2013-08-21", "completion_date": "2020-03-02", "has_results": true, "last_update_posted_date": "2021-12-22", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 22, "location_summary": "Bakersfield, California • Miami Beach, Florida • Atlanta, Georgia + 18 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Lacombe", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT01925794" }, { "nct_id": "NCT01327846", "title": "Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Atherosclerosis" ], "interventions": [ { "name": "Canakinumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Standard of care", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 10066, "start_date": "2011-04-11", "completion_date": "2019-04-14", "has_results": true, "last_update_posted_date": "2020-01-22", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 315, "location_summary": "Athens, Alabama • Birmingham, Alabama • Fairhope, Alabama + 248 more", "locations": [ { "city": "Athens", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Fairhope", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT01327846" }, { "nct_id": "NCT00281879", "title": "Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Chronic Myeloproliferative Disorders", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Myelodysplastic/Myeloproliferative Neoplasms", "Unusual Cancers of Childhood" ], "interventions": [ { "name": "anti-thymocyte globulin", "type": "BIOLOGICAL" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "busulfan", "type": "DRUG" }, { "name": "carmustine", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "cyclosporine", "type": "DRUG" }, { "name": "cytarabine", "type": "DRUG" }, { "name": "etoposide", "type": "DRUG" }, { "name": "fludarabine phosphate", "type": "DRUG" }, { "name": "melphalan", "type": "DRUG" }, { "name": "methotrexate", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "mycophenolate mofetil", "type": "DRUG" }, { "name": "tacrolimus", "type": "DRUG" }, { "name": "peripheral blood stem cell transplantation", "type": "PROCEDURE" }, { "name": "umbilical cord blood transplantation", "type": "PROCEDURE" }, { "name": "radiation therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "PROCEDURE", "RADIATION" ], "sponsor": "OHSU Knight Cancer Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "60 Years", "sex": "ALL", "summary": "Up to 60 Years" }, "enrollment_count": 200, "start_date": "2006-02", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2017-09-27", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 1, "location_summary": "Portland, Oregon", "locations": [ { "city": "Portland", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT00281879" }, { "nct_id": "NCT01647568", "title": "Safety of Continuing Anti-platelet Agents During Colonoscopic Polypectomy: A Prospective Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-polypectomy Bleeding", "Anti-platelet Therapy", "Colonoscopy" ], "interventions": [], "intervention_types": [], "sponsor": "Dallas VA Medical Center", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 715, "start_date": "2009-12", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-07-23", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01647568" }, { "nct_id": "NCT01455935", "title": "Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Stroke" ], "interventions": [ { "name": "Anti-platelets and statin", "type": "DRUG" }, { "name": "alteplase", "type": "DRUG" }, { "name": "intra arterial intervention", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Jacobs Neurological Institute", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 90, "start_date": "2011-11", "completion_date": "2014-02", "has_results": false, "last_update_posted_date": "2012-03-30", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 1, "location_summary": "Buffalo, New York", "locations": [ { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01455935" }, { "nct_id": "NCT02508116", "title": "Assessment of Prospective CYP2C19 Genotype Guided Dosing of Anti-Platelet Therapy in Percutaneous Coronary Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Acute Coronary Syndrome", "Cardiovascular Diseases" ], "interventions": [ { "name": "CYP2C19 genotyping", "type": "GENETIC" } ], "intervention_types": [ "GENETIC" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 509, "start_date": "2014-11", "completion_date": "2017-08", "has_results": true, "last_update_posted_date": "2018-11-07", "last_synced_at": "2026-10-05T05:53:35.685Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02508116" } ] }